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Abstract 
Microglia cells are the resident macrophages of the central nervous system and their 
activation plays a critical role in inflammatory reactions associated with many brain disorders, 
including ischemia, Alzheimer and Parkinson’s diseases and epilepsy. Yet, the changes of 
microglia functional properties in epilepsy have rarely been studied. Here, we used a model of 
status epilepticus (SE) induced by intra-peritoneal kainate injections to characterize the 
properties of microglial cells in hippocampal slices from CX3CR1eGFP/+ mice. SE induced 
within 3 hours an increased expression of inflammatory mediators in the hippocampus, 
followed by a modification of microglia morphology, a microglia proliferation and a 
significant neurodegeneration in CA1. Changes in electrophysiological intrinsic membrane 
properties of hippocampal microglia were detected at 24-48 hours post SE with, in particular, 
the appearance of new voltage-activated potassium currents. Consistent with the observation 
of an up-regulation of purinergic receptor mRNAs in the hippocampus, we also provide 
pharmacological evidence that microglia membrane currents mediated by the activation of P2 
receptors, including P2X7, P2Y6 and P2Y12, were increased 48 hours after SE. As a 
functional consequence of this modification of purinergic signaling, motility of microglia 
processes toward a source of P2Y12 receptor agonist was twice faster in the epileptic 
hippocampus. This study is the first functional description of microglia activation in an in 
vivo model of inflammation and provides evidence for the existence of a specific microglial 
activation state after a status epilepticus. 
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Introduction 
Increasing evidence indicates that inflammation is a landmark for a number of acute and 
chronic brain disorders including neuropathologies associated with seizures (Rock and 
Peterson, 2006;Choi and Koh, 2008). For instance, an increased expression of inflammatory 
markers has been observed in surgically resected temporal tissues from patients with temporal 
lobe epilepsy (Sheng et al., 1994;Crespel et al., 2002;Vezzani and Granata, 2005). A similar 
inflammatory reaction has also been reported in experimental models of temporal lobe 
epilepsy. In particular, an increase of pro-inflammatory cytokines and of markers of the innate 
immunity (IL-1β , IL-6, TNF-α NF-κB system, COX-2, prostaglandins, Toll-like receptors) 
has been detected in the rat hippocampus, starting within the first hour following the 
induction of a status epilepticus and lasting several days (Eriksson et al., 1999;De Simoni et 
al., 2000;Vezzani et al., 2008). 
Microglia and astrocytes represent the major source of pro-inflammatory molecules and they 
play a critical role in determining the spatial and temporal extent of inflammation as well as 
its impact on neuronal function and survival (Wyss-Coray and Mucke, 2002;Hanisch and 
Kettenmann, 2007;Vesce et al., 2007;Viviani et al., 2007). Accordingly, microglia and 
astrocytes become reactive after a status epilepticus. In the case of microglia, this activation 
has been well documented in terms of changes in morphology and expression of specific 
markers (Vezzani and Granata, 2005). Yet, activation of microglial cells is a complex process 
that includes changes in pharmacological and electrophysiological properties, migration, 
proliferation and release of a variety of mediators (Farber and Kettenmann, 2005;Hanisch and 
Kettenmann, 2007). However, these functional properties have never been investigated in 
epileptic tissues. Furthermore, different stimuli and stimulatory contexts can trigger different 
activation states of microglial cells and the concept of a continuum of activation between 
quiescent and fully activated microglia has recently emerged (Hanisch and Kettenmann, 
2007). Thus, the specific state of microglia after a status epilepticus cannot be inferred from 
our knowledge of other models.  
Among the key signals that govern microglia activation, several lines of evidence indicate that 
ATP released by glia and neurons and acting through ionotropic (P2X) and metabotropic 
(P2Y) purinergic receptors regulates numerous aspects of microglia activation (Inoue et al., 
2007). In particular, specific functions of different purinergic receptors in microglia have been 
identified pointing at essential roles of P2Y6 in phagocytosis (Koizumi et al., 2007), P2Y12 
in the polarization, migration and process extension (Davalos et al., 2005;Haynes et al., 
2006;Ohsawa et al., 2007) and P2X receptors in the secretion of pro-inflammatory molecules 
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from microglial cells (Tsuda et al., 2003;Coull et al., 2005;Chessell et al., 2005;Skaper et al., 
2006). Interestingly, activation of microglia can differentially regulate the expression of its 
purinergic receptors in different models, as reported for P2X4, P2X7, P2Y6 and P2Y12 
(Tsuda et al., 2003;Franke et al., 2004;Haynes et al., 2006;Koizumi et al., 2007;Kobayashi et 
al., 2008). 
The aim of the present work was to characterize the activation state of hippocampal microglia 
during the inflammatory reaction which occurs in a non invasive model of status epilepticus 
(i.e. intra-peritoneal injection of kainate) in mice. We used CX3CR1eGFP/+ mice in which 
microglia expresses the green fluorescent protein and retains normal functional properties 
(Cardona et al., 2006), allowing the comparison of cellular characteristics between non-
activated and activated microglia. Our data provide the first comprehensive functional 
characterization of activated microglia in the epileptic hippocampus. 
 
Materials and Methods 
Animals and seizure inductions 
All experiments followed European Union and institutional guidelines for the care and use of 
laboratory animals (Council directive 86/609EEC). The heterozygous CX3CR1eGFP/+ mice 
used throughout this study were obtained by crossing CX3CR1eGFP/eGFP (Jung et al., 2000) 
with C57BL/6 (Janvier, Le Genest Saint Isle, France) wild type mice. Intra-peritoneal (i.p.) 
injection of kainate (18-22 mg/kg) in phosphate buffer saline (PBS) was used to induce a 
status epilepticus in 30 to 40 day-old mice, while age matched PBS injected animals were 
used as control. Animals were observed and classified according to the Racine scale: 1) 
freezing behaviour; 2) rigid posture with straight and rigid tail; 3) repetitive head bobbing, 
rear into a sitting position with forepaws shaking; 4) rearing and falling , jumping, running 
with period of total stillness; 5) continuous level 4; 6) lost of posture and generalized 
convulsion activity, usually preceding death. After kainate injection, mice showed 
progression through the different stages, usually entering in phase 1 between 15 minutes after 
the injection and reaching stage 3 in 30-45 minutes. Animals not showing the normal 
progression were re-injected with half dose. Only animals reaching at least stage 4 were 
considered for this study. The duration of crises varied from 2 to 4 hours and mortality was 
around 20%. 
 
Western blotting 
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The hippocampi of three mice per condition were homogenized in a lysis buffer (10mM 
HEPES buffer pH 7.4), 0.5% Triton X-100, and protease inhibitor cocktail (Roche Applied 
System). Lysates were clarified by centrifugation and protein concentration determined using 
protein assay kit (Biorad). Proteins were separated on reducing 12 % SDS– PAGE, and 
transferred on nitrocellulose membrane. The membrane was blocked with 5% non-fat dry 
milk/ 0.5% Tween 20 in Tris buffer saline (TBST) overnight at 4°C. The membrane was 
incubated overnight at 4°C with a rabbit anti-Iba1 (1/1000, Wako Chemicals GmbH, Neuss, 
Germany) in TBST and with mouse anti-tubuline (1:2500, Sigma-Aldrich, Lyon, France). 
After three washes in TBST, the membrane was then treated with HRP-conjugated secondary 
antibody for 1h at room temperature and revealed with ECL+detection kit (Amersham). 
 
Histochemistry 
Mice were anesthetized with pentobarbital (50mg/kg) or Urethane (2g/Kg) and perfused 
transcardiacally with 4% paraformaldehyde in 0.1M phosphate buffer. Brains were dissected 
out, post-fixed for 2 hours or overnight at 4°C, and 50 µm thick slices were prepared with a 
VT 1000 Leica vibratome. Slices were washed 3 times with PBS and incubated for 2h with 
PBS containing 2 % Bovine Serum Albumine (Sigma-Aldrich, Lyon, France) and 0.1 % 
Triton X-100 (Sigma-Aldrich, Lyon, France). After 3 washes, slices were incubated overnight 
with primary antibodies for microglia markers Iba1 (rabbit polyclonal, 1/1000, Wako 
Chemicals GmbH, Neuss, Germany), MAC2 (1/1000, rat monoclonal, kindly provided by M. 
Benhamou, obtained from hybridomas (TIB-166) distributed by ATCC), P2Y12 (1/200, 
kindly provided by David Julius). Ki67 antibody (mice monoclonal, 1/20, BD Pharmigen) 
was used to assess cell proliferation. Appropriate secondary antibodies were applied for 2 
hours at room temperature, included anti-rabit/anti-rat IgG Alexa fluor 568/555 (1/1000, 
Invitrogen, Paisley, UK), anti-mouse IgG Alexa fluor 555 (1/1000, Chemicon). After staining, 
brain slices were mounted in Vectashield H1400 (Vector lab, distributed by Abcys, Paris 
France) and examined with a confocal laser-scanning microscope (Zeiss 510). 
To assess neuronal damage, slices were incubated with eosin-hematoxylin solution for 10 
seconds following by 5 washes with distilled water. For Fluorojade B staining, slices were 
successively immersed at room temperature in a solution of 5% NaOH in 80% ethanol for 5 
min, 2 min in 70% ethanol, 2 min in distilled water, 10 min in 0.06% potassium 
permanganate, 2 min of distilled water. Slices were incubated for 20 min with 0.004% 
FluorojadeB in a 0.1% acetic acid and rinsed by 3 washes with distilled water. Slices were 
mounted and images of the hippocampal rostral region were captured with a Leica DMRA2 
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fluorescence microscope equipped with a 20x objective. To quantify FluorojadeB positive 
cells, three mice per condition (PBS or 48 hours after SE) were used. For each hippocampus, 
usually two fields (452x338µm) were necessary to acquire the whole CA1 and CA3 regions, 
and five consecutive sections were analysed. Fluorojade B positive neurons were manually 
counted in both areas. Results are reported as the number of positive neurons per field of view 
and expressed as mean ± SEM. 
 
Quantification of the number of microglial cells 
GFP positive cells were counted in confocal sections taken with 40x objective (size of the 
field of view 230x230 µm). Similar laser intensity were used to acquire pictures of PBS- and 
kainate-injected animals. Cells were counted in 3 to 11 slices from each animal and 3 to 7 
animals were analyzed for each condition. The number of cells counted in different slices of 
each animal was quite homogeneous and followed a Gaussian distribution. For each 
condition, we calculated the weighted average and its relative standard error to the mean 
(SEM). Anova with post-hoc Tukey test was applied to test significance between different 
groups. 
 
RNA extraction and RT-PCR 
Hippocampi from PBS- or kainate-injected mice were collected, frozen in liquid-nitrogen and 
stored at -80°C until RNA extractions were performed. Total RNA were extracted using the 
Trizol reagent (Invitrogen, Paisley, UK), then genomic DNA was digested using RNase-free 
DNase set (Qiagen) according the to the manufacturer’s protocols. Total RNA (2µg) was 
reverse transcribed into cDNA with random hexamers in a 20µl reaction by using a 
SuperScript III reverse transcriptase kit (Invitrogen, Paisley, UK). Quantitative real-time PCR 
(qRT-PCR) was performed in duplicate using four to six independent RNA samples. The 
cDNA was quantified using the Quantitect SYBR Green PCR kit and the Quantitect Primer 
assay kit (Qiagen) according to the manufacturer's instructions. The PCR amplification was 
run on 10µl of cDNA generated from 40 ng of total RNA and using an ABI PRISM 7900HT 
Sequence Detection System (Applied biosystems). For each reaction we calculated the 
difference (ΔCt) between the cycle threshold (Ct) of the gene of interest and that of the 
housekeeping gene hypoxanthine-guanine phosphoribosyltransferase (HPRT). To quantify the 
fold changes in expression of each gene in kainate-injected animals compared to control, we 
first calculated the mean of ΔCt obtained in four PBS injected animals (ΔCtmPBS). Then, for 
each kainate-injected animal, we calculated the ratio between (2-ΔCt) and (2-ΔCtmPBS), i.e. 2-(ΔCt-
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ΔCtmPBS) which estimates the fold change in expression of a given gene relative to the control 
animals (Livak and Schmittgen, 2001). Results are presented as the mean ± SEM. Statistical 
significance compared to control was calculated using Student’s t-test with Welch’s 
correction, since standard deviations are usually different, and was established at *p<0.05 and 
**p<0.01. 
 
In vivo electrophysiological recordings 
Mice were anesthetized with ketamine (100mg/Kg) and xylazine (5 mg/kg) and placed into a 
stereotaxic frame. Skulls surface was exposed and five electrodes were placed as following: 
Four extradural electrodes were inserted bilaterally in the parietal areas and one screwed at 
the level of the frontal area (ground electrode). Electrodes were plugged in a micro-connector 
with acrylic cement. After surgery, mice were allowed to recover for one week before 
recording. Freely moving animals were placed into individual Plexiglass boxes in a Faraday 
cage and their microconnectors plugged to an electroenphalographic (EEG) pre–amplifier box 
(Reega mini8, Alvar, Montreuil, France). The electrical activity recorded by derivation 
between extradural electrodes was filtered (pass-band 0.5-60 Hz) and acquired with a 
computer-based system (Micromed, Saint Etienne des Ouillères, France).  
 
In vitro electrophysiological recordings 
Hippocampal slices were obtained from 30-40 day old mice. Animals were killed by cervical 
dislocation, the brain was then quickly removed and placed in ice-cold artifical cerebrospinal 
fluid (aCSF) bubbled with carbogene (95% CO2/5% O2) and in which NaCl was replaced with 
sucrose (in mM: 210 sucrose, 2.5 KCl, 26 NaHCO3, 1.25 NaH2PO4, 25 glucose, 1 CaCl2, 7 
MgSO4; pH 7.4, osmolarity ~310 mOsm). Transverse 350 µm thick slices were cut using a 
vibratome, transferred to a heated (34ºC) holding chamber containing oxygenated (95% 
CO2/5% O2) standard aCSF (in mM: 124 NaCl, 3 KCl, 26 NaHCO3, 1.25 NaH2PO4, 10 
glucose, 2 CaCl2, 1 MgCl) for 1h, and then subsequently maintained at room temperature.  
Individual slices were transferred to a recording chamber on the stage of an Olympus 
microscope (BX50WI) with a 40x water immersion, equipped with cell-R imaging station 
including MT20 illumination system (Olympus, France) and a CCD camera (Hamamatsu 
ORCA2-AG, Massy, France). Slices were constantly perfused at room temperature (21-24ºC) 
with oxygenated aCSF (3 ml/min). Unless otherwise stated, all drugs were applied through 
the general perfusion. Visually-identified GFP-expressing microglial cells were patched in 
whole-cell configuration in the stratum radiatum of the CA1 region of hippocampus. 
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Micropipettes (5 to 7 MΩ) were filled with a solution containing (in mM): K-gluconate 132, 
HEPES 11, EGTA 0.1, MgCl 4 (pH 7.35 adjusted with KOH, osmolarity ~300 mOsm), or Cs-
gluconate 125, HEPES 10, EGTA 0.2, MgCl 1 (pH 7.35 adjusted with CsOH, osmolarity 
~300 mOsm). Voltage-clamp recordings were performed using an Axopatch 200B (Axon 
Instrument, Union City, CA). Currents were low-pass filtered at 1-5 kHz, collected using 
PClamp 9 (Axon Instrument, Union City, CA) at a frequency 2-10 kHz and analyzed off line. 
An electrophysiological characterization in voltage-clamp was made at the beginning of the 
recording. Hyperpolarizing and depolarizing steps (from –140 to +40 mV for 50 ms) were 
used to determine I/V relationship of each recorded cell. Membrane input resistance and 
capacitance of the cells were determined from the current responses to voltage pulses ranging 
from – 20mV to +20 mV from a holding potential of -60mV.  
The responses induced by the activation of purinergic receptors were studied by bath applying 
ATP or selective agonists. In preliminary experiments, we observed that the responses to a 
second application, even performed after a delay of 15 to 20 minutes, could be different from 
the first one. This was particularly obvious for responses mediated by the activation of P2Y 
receptors studied with whole-cell recordings during which a wash-out of the evoked 
potassium currents occurred after about 10 minutes of dialysis. Changes in amplitude or 
kinetics were sometimes also observed for P2X receptor-mediated currents. Bath applications 
of agonists were therefore tested only once per slice. Consequently, all comparisons were 
done by testing differences between mean responses obtained from 1 microglia per slice, 3 to 
4 slices per animal and 3 to 6 animals per experimental groups. The I/V curve of the 
responses induced by the activation of purinergic receptors were determined by subtracting 
the current responses to the same voltage step protocol applied in control conditions from 
those obtained in the presence of the agonists. 
Data were analyzed off-line using Clampfit (Axon Instrument, Union City, CA). Data values 
are presented as mean ± SEM. Statistically significance was tested with the program 
GraphPAd Instat. First we tested if data were sampled from populations that follow Gaussian 
distributions using the method Kolmogorov and Smirnov. Then according to the result, non-
parametric test (Mann-Whitney) or parametric test that assumes the standard deviation can be 
different (t-test with Welch’s correction) were used to compare results between the two 
groups of data. Statistical significance was established at *p<0.05 and **p<0.01.  
 
Imaging experiments 
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Slice were placed in the recording chamber at 34°C and after 5 minutes (taken as t0) a pipette 
containing 2-MeSADP (100µM) was placed in the stratum radiatum in the center of the field 
of view. Movement of microglia processes were followed by taking a fluorescent image every 
minute though a 40X water immersion objective (Olympus, NA 0.8). To quantify the 
elongation of the GFP positive processes toward the pipette we measured the fluorescence in 
two concentric circles, one close to the pipette (Fcint, blue circle in fig 8) and a second 
covering almost the whole field of view (Fcext, light blue circle in fig 8). We then calculated 
the ratio of the fluorescence in the two circle at different time point (t) and subtracted the ratio 
at t0  
Fcint(t)/Fcext(t) - Fcint(t0)/Fcext(t0),  
The obtained values were then normalized to the maximum. 
To estimate the velocity at which the fluorescent processes elongated toward the pipette, a 
series of concentric circles were drawn as region of interest and the fluorescent was measured 
in concentric rings (Fr). Since the microglia processes approach the pipette with 
approximately a circular symmetry, it was possible to observe for each ring a maximum in the 
temporal course of the fluorescence. Fr was normalized to the fluorescence of the external 
circle, and the following ratio was calculated for each ring 
                                              Fr(t)/ Fcext (t)-Fr(t0)/ Fcext (t0) 
and then normalized to its maximum.  
To define the velocity, the distance between two coronal sections was divided by the time 
difference between the corresponding two peaks of fluorescence. We considered only the 
experiments where we could clearly identify at least three peaks of fluorescence in three 
coronal sections, thus two velocities, and the mean was taken as the representative velocity of 
each experiment. Data are given as mean ± SEM, and a Student's t-test with Welch’s 
correction was used to compare results between control and kainate injected mice. Statistical 
significance was established at *p<0.05 and **p<0.01. 
 
Reagents  
Tetrodotoxin (TTX), D-(-)-2-Amino-5-phosphonopentanoic acid (D-AP5), 2,3-Dioxo-6-nitro-
1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX), gabazine, kainate, 
Pyridoxalphosphate-6-azophenyl-2',5'-disulfonic acid (iso-PPADS), 4-Aminopyridine, LY 
341495; 8-cyclopentyl-1-3-dipropylxanthine (DPCPX)  were purchased from Tocris 
Bioscience (Bristol, UK) or Ascent Scientific (Weston-Super-Mare, UK); 2-
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(Methylthio)adenosine-5'-(trihydrogen diphosphate) (2-MeSADP), Brilliant Blue G (BBG), 
ATP, UDP, ivermectine, from Sigma-Aldrich (Lyon, France). 
In experiments involving BBG, slices were incubated in a solution containing BBG (3µM) for 
30 min at 37°C 3µM and then kept at room temperature until the experiment.
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Results 
Characterization of kainate-induced status epilepticus model in C57BL/6 CX3CR1eGFP/+ mice 
To study microglia activation during the early phases of epilepsy, we used i.p. injections of 
kainate as a non-invasive model of status epilepticus (SE). In rats, systemic injection of 
kainate has been considered as valuable model of temporal lobe epilepsy (Ben Ari and 
Cossart, 2000). However, models of experimental epilepsy are less well characterized in mice 
and the susceptibility to seizures varies dramatically across mouse strains (Schauwecker, 
2002). Therefore, we first characterized the inflammatory reaction and the extent of neuronal 
damage in the hippocampus of the CX3CR1eGFP/+ mice following a status epilepticus.  
Eighty percent of the kainate-injected mice survived of which 70 % developed a status 
epilepticus corresponding to stages 4 or 5 on the Racine scale (see methods) and were used 
for subsequent analysis. Quantitative PCR experiments performed on hippocampi from 4 
control mice and 4-6 kainate-injected mice revealed a 10 to 22 fold increase in  the expression 
of the mRNAs coding for the pro-inflammatory molecules IL-1β, IL-6, TNF-α and COX-2 
(fig 1A) 3 hours after SE. At 24 hours post SE, the expression of TNF-α was further increased 
(80. 7 +/- 9.2 fold) compared to 3 hours (19.7 +/- 5 fold) while that of COX2 was decreased 
(5.7 +/- 1.6 versus 22.6 +/- 1.9 at 3 hours), but remained higher than in control animals. At 48 
hours post SE, the increase in expression of the 4 genes was more variable and remained 
significant only for TNF-α and COX-2. These results confirmed the occurrence of an 
inflammatory reaction during the 48 hours that follow a SE and which is comparable to that 
observed in other experimental models of epilepsy (Vezzani and Granata, 2005). 
We then examined neuronal damage in the hippocampus of CX3CR1eGFP/+ mice at 24 and 48 
hours post SE with eosin-hematoxylin staining. Following SE, there was a time-dependent 
increase of the number of black and large neuronal morphologies observed in the cell layers 
of the hippocampus. Neuronal degeneration was first observed in CA3 24h after SE (data not 
shown) and extended to the CA1 area 48h after SE (Fig 1B). Similar observations were made 
using the specific degenerating marker Fluorojade B (Schmued and Hopkins, 2000). While no 
staining was observed in control mice, many neurons were labeled at 24h (data not shown) 
and 48h after the induction of SE. The number of cells per field of view (442 x 338 µm) 
counted 48h post SE was 31.5 ± 2.7 and 18 ± 2.42 in CA1 and CA3 regions, respectively. 
These observations are in good agreement with a previous study reporting neuronal damage in 
the hippocampus of C57BL/6 mice after kainate-induced seizures (Benkovic et al., 2004), 
even though neuronal degeneration in these mice is clearly less massive than in other mouse 
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strains as previously shown (McKhann et al., 2003). Furthermore, in vivo EEG recordings 
performed 48h post SE (n=4 animals) but also 50 days post SE (n=2 animals) revealed the 
occurrence of bilateral synchronized bursting activities (Fig. 1D) which were not observed in 
control mice (n=4 animals). 
Altogether, these data indicate that kainate-induced seizures in CX3CR1eGFP/+ mice lead to an 
inflammatory reaction associated with neuronal death in the hippocampus and trigger long 
term changes of electrical brain activity. Because neuronal damage appeared more 
pronounced in CA1, we focused our investigation of microglia activation in this region of the 
hippocampus. 
 
Activation of Microglia after kainate-induced SE 
As previously reported for the CX3CR1eGFP/+ mouse line (Cardona et al., 2006), GFP co-
localized with the specific marker of microglia Iba1 (fig 2A), but not with the neuronal 
marker NeuN, the astrocytic marker GFAP nor with NG2, a marker of oligodendrocyte 
precursors (data not shown). We then investigated changes in microglia morphology and 
immuno-reactivity in the hippocampus 3, 24 and 48 hours after the induction of the SE. A 
higher Iba1 immuno-reactivity was first observed by immuno-fluorescence in the 
hippocampus of treated animals 24h after the kainate injection (fig. 2A). At this stage 
microglia had larger soma and thicker primary processes when compared with control animals 
(fig 2A). We never observed, however, GFP positive cells with amoeboid macrophage-like 
morphology. At 48h post SE, similar changes of morphology and Iba1 immuno-reactivity 
were observed and the increased expression of Iba1 was confirmed by a Western blot analysis 
performed on hippocampal extracts (Fig 2B; 3 control and 3 epileptic mice).  
This increased expression of Iba1 proteins in the hippocampus of epileptic mice could be in 
part explained by a change in the number of microglia. We thus evaluated whether there were 
a proliferation of microglial cells in kainate injected mice. At 24 and 48h after the induction 
of SE there was a significant increase (ANOVA test, p<0.001) in the number of microglial 
cells in CA1 (fig 2C). The number of cells per field of view (230 x 230 µm) rose from 16.96 ± 
0.54 in control to 25.31 ±0.61 after 24h and to 31.80 ± 0.54 after 48h. Post-hoc Tukey test 
revealed significant difference (p<0.001) between all groups. This proliferation of microglia 
was similar in the dorsal and ventral hippocampus (data not shown). Consistent with the 
increase number of microglia, immuno-stainings for the proliferation marker ki67 and for 
MAC2, a specific marker of activated microglia in proliferation (Lalancette-Hebert et al., 
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2007) were observed in microglial cells in the CA1 area 24h after the kainate injection and 
became more evident at 48h (fig 3). 
Thus, status epilepticus evoked by systemic injection of kainate in CX3CR1eGFP/+ mice 
triggers an activation of hippocampal microglia characterized by a change in morphology and 
a cell proliferation. 
 
Intrinsic membrane properties of activated and non-activated microglia 
There has been a limited number of studies on the electrophysiological properties of microglia 
in situ but work in cultures showed that changes of intrinsic membrane properties occurs 
during microglia activation (Farber and Kettenmann, 2005). We thus used whole-cell 
recordings in acute hippocampal slices of control and epileptic CX3CR1eGFP/+ mice to 
characterize electrophysiological properties of microglial cells identified by the expression of 
GFP. Because the slicing procedure might result in activating microglia, in particular near the 
surface of the slice, recordings were obtained from cells usually at a depth below 30 µm from 
the slice surface. In addition, experiments were completed within the first 4 hours after 
slicing.  
Resting microglial cells in slices of control mice had a high membrane input resistance of 
3.6±0.2 GΩ and a membrane capacitance of 28.1±1.0 pF (n=37, Fig. 4A). Application of 
hyperpolarizing and depolarizing voltage steps from a holding potential of –60 mV did not 
induce large voltage dependant membrane currents (Fig. 4B) and the membrane I/V 
relationship was almost linear (Fig. 4C). Microglial cells recorded 3h after SE had similar 
intrinsic membrane properties (n=7, Fig. 4B & C) while at 24h post SE microglia had a larger 
membrane capacitance (32.9±1.8 pF; p=0.018, n=15) when compared to control mice but a 
similar input resistance (3.0±0.3 GΩ; p=0.17). In addition, voltage activated currents were 
evoked when applying hyperpolarizing and depolarizing pulses (Fig. 4B), leading to 
rectifications in the I/V curve (Fig. 4C). Forty eight hours after SE, microglia cells had larger 
membrane capacitance (35.6 ± 1.6, p<0.001; n=42) and lower input resistance (2.2±0.1 G, 
p<0.001) compared to control mice. Moreover, inward currents evoked by hyperpolarizing 
pulses were smaller while outward currents evoked by depolarizing pulses were larger than at 
24h post SE (fig. 4C). As illustrated in figure 4C, the difference in amplitude described for 
voltage activated currents remained significant when normalizing the current values to the cell 
capacitance to take into account the difference in cell size between non-activated and 
activated microglia. Both inward and outward currents were absent when microglia was 
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recorded with an intracellular solution containing the non-selective potassium channel blocker 
Cesium, while outward currents were abolished by 4-aminopyridine (1 mM, n=4, data not 
shown), a blocker of outward rectifying potassium channels. These results indicate that 
intrinsic membrane properties of microglia gradually evolve during the first two days that 
follow a SE. 
 
Increased expression of purinergic receptor mRNAs in the hippocampus after status 
epilepticus 
Activation of purinergic receptors plays an essential role in different processes of microglia 
activation (Sperlagh et al., 2006;Farber et al., 2008). We therefore tested whether their 
expression was changed after SE. Quantitative PCR was performed on whole hippocampi 
from control animals and 3, 24, 48 hours after the induction of status epilepticus to compare 
the mRNA expression of ionotropic P2X1, P2X4 and P2X7 and of metabotropic P2Y6, 
P2Y12 and P2Y13 purinergic receptors. This specific set of receptors has been selected on the 
basis of previous studies that have established their expression in microglia or macrophages 
((Inoue et al., 2007). Already 3h after SE there was a small but significant increase (1.60 ± 
0.05 fold) in the expression of P2Y6 mRNAs whereas that of P2X4 and P2Y13 mRNAs 
decreased and that of P2X1, P2X7, P2Y12 and P2Y13 mRNAs did not change significantly 
(Fig. 5). The pattern of expression of these receptors 24h after status epilepticus was 
characterized by an important increase of P2Y6 mRNAs expression (9.2+/-1.5 fold). Forty 
eight hours after SE, the expression of all 4 receptors was above control values with a 7.5 ± 
1.2 fold increase for P2Y6, a 3.5 ± 0.2 fold increase for P2Y12, a 3.4 ± 0.2 fold increase for 
P2X1, a 2.0 ± 0.2 fold increase for P2Y13, a 2.0 ± 0.2 fold increase for P2X4 and a 1.9 ± 0.2 
fold increase for P2X7 receptor mRNAs. 
These results suggest that all purinergic receptors known to be expressed in microglia are up-
regulated in the hippocampus 48h after SE. In the case of P2Y12 receptors, our results 
contrast markedly with the down-regulation of this receptor in some other models of 
microglia activation (Moller et al., 2000;Haynes et al., 2006). Because the qPCR analysis was 
performed on total RNA from whole hippocampi and not on isolated microglia, we verified 
by immuno-cytochemistry that the expression this receptor was indeed restricted to microglia 
and was not down-regulated in the hippocampus 48h after SE (supplementary fig.1). 
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Enhanced purinergic responses of activated microglia after status epiletpicus 
We then tested whether the enhanced expression of purinergic receptor mRNAs in the whole 
hippocampus after SE correlated with changes in responses of microglia to purinergic 
receptor activation. A preliminary series of experiments in control animals showed that 
hippocampal microglia cells respond to bath applied ATP (1mM for 2 min) with a complex 
response composed of inward and outward currents probably mediated by P2X and P2Y 
receptors, respectively. These responses were not altered by blocking synaptic transmission 
(n=5) with TTX (1µM), NBQX (10µM), APV (50µM) and gabazine (5µM), while they were 
greatly reduced by the large spectrum antagonist of purinergic receptors PPADS (100µM; 
n=3, data not shown). New series of experiments were therefore designed to analyze the effect 
of status epilepticus on isolated P2X and P2Y receptor-mediated components of these 
responses. 
Responses mediated by the activation of P2X receptors were isolated by recording microglia 
with an intracellular solution containing Cesium to block potassium currents induced by P2Y 
receptor activation (Fig. 6A). Inward currents evoked by ATP (1mM for 2 min) at a holding 
potential of – 40 mV had an average amplitude of 4.8 ± 0.6 pA (n=12) in microglia of control 
mice. These currents had an I/V curve which presented a slight inward rectification with a 
reversal potential near 0 mV, as expected for non selective cation permeable channels (Fig. 
6A). The amplitude and the I/V curve of these responses (n=4) were not altered in the 
presence of a cocktail aimed at reducing indirect effects through neuronal activation and 
including TTX (1µM), NBQX (10µM), APV (50µM) and gabazine (5µM) (supplementary 
figure 2). Removing extracellular divalent ions greatly increased the amplitude of the ATP-
induced currents (49.3 ± 7.6 pA at -40 mV, n=6) without changing the form of the I/V curve 
(Fig. 6B & 6C). The antagonist of P2X7 receptors, Brillant Blue G (BBG, 3 µM) blocked a 
large part of the ATP currents (residual current at -40 mV: 1.6 ± 0.3, n=3) and the further 
addition of the antagonist of ionotropic purinergic receptors isoPPADS (50 µM) did not 
antagonize more the responses (Fig. 6C). The sensitivity of the responses to extracellular 
divalent cations and to BBG suggests that P2X7 receptors were responsible for most of the 
response induced by ATP in non-activated microglia.  
The responses due to the activation of ionotropic purinergic receptors in activated microglia 
were then analyzed 48h after SE when the enhanced expression of the corresponding mRNAs 
was most pronounced (see above and Fig. 5). The amplitude of the currents induced in 
standard extracellular medium by ATP was larger in activated microglia than in control mice 
(13.2 ± 1.9 pA, n= 14; p<0.01). As illustrated in figure 6A and 5C, this difference remained 
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significant when normalizing the current values to the cell capacitance to take into account the 
difference in cell size between non-activated and activated microglia. As shown in figure 6C, 
the responses were greatly reduced by BBG (3 µM) but in contrast to the responses of non-
activated microglia, the residual current (3.9 ± 0.4 pA at -40mV, n=5) was further decreased 
by adding isoPPADS (residual current: 1.7 ± 0.4pA, n=4). As in non-activated microglia, 
removing divalent cations from the extracellular solution enhanced ATP responses of 
microglia from epileptic mice and these responses were larger (156.9 ± 23.0 pA; n=9; Fig 6B 
& 6C) compared to control animals (p<0.01). BBG (3µM) decreased ATP responses in Mg-
Ca-free solutions and the residual current (28.8 ± 6.8 pA, n=4) was further reduced by adding 
isoPPADS (5.8 ± 1.0 pA, n=3). These results indicate a higher expression of functional P2X7 
receptors in activated microglia and suggest the presence of another type of P2X receptor 
responsible of the BBG resistant component of the response. It is worth noting that ATP 
responses recorded in our experimental conditions were not sensitive to the positive 
modulator of P2X4 receptors, ivermectin (5 µM, data not shown), suggesting that these 
receptors did not mediated the BBG resistant component observed in activated microglia.  
We then investigated the responses to P2Y receptor activation. Microglia cells were voltage 
clamped at –20mV with a K-gluconate based internal solution and the responses to bath 
applied selective agonists of P2Y receptors were tested. The P2Y6 agonist UDP (1 mM, 1 
min) induced an outward current in all microglia recorded in hippocampal slices of both 
control and epileptic animals (Fig. 7A). However, the amplitude current induced in activated 
microglia was about six times larger in epileptic animals (7.1 ± 1.1pA, n=9, and 44.3 ± 11pA, 
n=8, in control and kainate injected animals, respectively; p=0.01). As for P2X receptor 
mediated responses, this difference was not due to the larger size of activated microglial cells 
since it remained significant when the responses were expressed in current densities (Fig. 7).  
Differences between control and epileptic mice were also observed with an agonist at both 
P2Y12 and P2Y13 receptors, 2-MeSADP (100µM, 1 minute): the currents induced in 
activated microglia (46.8 ± 13.8 pA, n=7) were significantly larger than those recorded in 
slices of control mice (6.5 ± 1.0, n=11, p< 0.05). The amplitude of the currents induced by 
both agonists decreased with hyperpolarization and reached their zero value close to -90 mV, 
as expected for potassium currents (see I/V curves in Fig. 7A & 7B). In addition, the 
amplitude and the I/V of responses to UDP (n=4) and to 2-MeSADP (n=4) were not altered in 
the presence of TTX (1µM), NBQX (10µM), APV (50µM), gabazine (5µM), LY341495 
(100µM) and DPCPX (1µM) (supplementary figure 2). 
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Thus, together with the results of quantitative PCR, these observations indicate the occurrence 
of an increase in expression of functional P2Y receptors receptors in activated microglia two 
days after a status epilepticus. 
 
Activated microglial cells have higher motility in the hippocampus of epileptic mice 
Microglia can readily send their processes towards an ATP source (Davalos et al., 
2005;Haynes et al., 2006) that, in pathological conditions, would be generated by damaged 
cells or a prolonged hyper-activity. This phenomenon is partially mediated by P2Y12 
receptors (Haynes et al., 2006). We therefore compared the elongation velocity of the 
processes of GFP expressing microglia in acute hippocampal slices of control and epileptic 
mice. In time-laps video-microscopy experiments, we observed that processes of microglia 
elongated towards a pipette containing ATP (1 mM, data not shown) or 2-MeSADP (100µM) 
in slices from both epileptic and control mice (see movies 1 and 2 in supplementary material). 
No directional movement was observed when the pipette contained extracellular solution 
without purinergic receptor agonist (data not shown). The velocity with which the processes 
reached the pipette was significantly faster in slices of epileptic animals compared to control 
(fig 8, A and B). To quantify these differences, we measured the temporal course of the ratio 
between the fluorescence in a circle around the pipette and that in a circle which covers 
almost the entire field of view. This ratio increased as the processes approach the pipette. The 
mean time to reach the maximum of this ratio was 54.7 ± 2.1 min in control animals (n=13) 
and 28.4 ±2.8 min in epileptic mice (n=14; p<0.01). 
There is a higher density of microglia in epileptic animals (see above Fig. 2C). Therefore, this 
difference could be due to the fact that more microglial cells are closer to the pipette 
containing purinergic agonist. We thus estimated the velocity by measuring the time 
differences at which peaks of fluorescence appeared in concentric rings along the elongation 
path toward the pipette (Fig. 8B and 8D, see methods for details). The estimated velocity in 
slices of control mice was 3.32 ± 0.24 µm/min (n=10) while that in kainate injected mice was 
5.85 ± 0.6 µm/min (n=10, p<0.01). To evaluate a possible contribution of neuronal activity, 
experiments with 2-MeSADP were repeated in the presence of TTX (1µM), NBQX (10µM), 
APV (50µM) and gabazine (5µM). The velocity with which microglia processes elongated 
toward the pipette containing the agonist was 3.19 ± 0.12 µm/min (n=7) in control animals 
and increased to 4.97 ± 0.49 µm/min (n=4) in epileptic mice (p<0.01). These values were not 
significantly different from those measured in normal medium (p>0.4). These observations 
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indicate that increased velocity of microglia processes observed after SE was a consequence 
of changes in P2Y receptor signaling in microglial cells. 
 
Discussion 
In addition to the observed changes in morphology and in Iba1 expression, our study provides 
the first description of microglia functional changes during the inflammatory reaction that 
follows a status epilepticus. We show that this activation is characterized by a proliferation, a 
modification of intrinsic membrane properties, an increase of purinergic receptor-mediated 
responses and an enhanced process motility of microglia.  
 
The model of status epilepticus in CX3CR1eGFP/+ C57BL/6 mice 
There is an important variability in the susceptibility of different mouse strains, in response to 
systemic injections of kainate, to develop seizures and to display the characteristic pattern of 
hippocampal neurodegeneration observed in rats (Pisa et al., 1980;Sperk et al., 1983;Ben-Ari, 
1985) and the strain C57BL/6 mice has been considered as one of the most resistant 
(Schauwecker and Steward, 1997;Schauwecker, 2002;McKhann et al., 2003;Mazarati et al., 
2004;Shikhanov et al., 2005). However, recent evidence indicates that seizures and some 
degree of hippocampal neurodegeneration also occur in these mice (Benkovic et al., 
2004;McLin and Steward, 2006;Benkovic et al., 2006). In agreement with these latter 
observations, we could trigger stage 4 to 5 seizures in CX3CR1eGFP/+ C57BL/6 mice and 
fluorajade B labeled a significant number of CA1 neurons after kainate-induced SE in these 
mice. This susceptibly was probably not a consequence of the use of mice heterozygotes for 
CX3CR1 since similar increases in the expression of inflammatory mediators were also 
observed in wild type C57BL/6 mice (data not shown). A previous study on the role of 
CX3CR1 receptors showed that the functions of microglia in various experimental models of 
brain disorders are impaired in CX3CR1eGFP/eGFP but not in CX3CR1eGFP/+ mice (Cardona et 
al., 2006). Together with the rapid and prolonged increase expression of pro-inflammatory 
molecules and the activation of microglia, our results thus validate the use of intra-peritoneal 
injection of kainate in these mice as a model of status epilepticus. Whether this status 
epilepticus leads to the development of chronic epilepsy remains to be established but our 
data suggest that kainate-treated mice have abnormal hippocampal hyper-excitability up to 2 
months after the induction of SE. 
 
Intrinsic membrane properties of microglia 
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Until recently, the difficulty to identify microglia has precluded the analysis of their 
functional state in situ and most of our current knowledge on electrophysiological properties 
of microglia and their changes during activation relies on studies performed in culture 
systems. There are few exceptions though and, similarly to what we observed in hippocampal 
slices of control mice, other studies  reported that non-activated microglia in acute brain slices 
has almost linear I/V curves with virtually no voltage activated channels (Boucsein et al., 
2000;Wu et al., 2007). Yet, cultured microglia expresses a prominent inward rectifying 
current at hyperpolarizing potentials in absence of any specific activation stimulus (Farber 
and Kettenmann, 2005). Boucsein et al (Boucsein et al., 2000) also observed in slices of the 
facial nucleus after lesion of the facial nerve that in activated microglia an inward rectifying 
current is first expressed, followed by the expression of additional outward currents. Our 
present study provides further support for this sequential activation of different voltage 
activated channels during the development of inflammation in situ, with the inward rectifying 
current being maximum first (i.e. at 24h post SE) and a delayed expression of the outward 
current. Furthermore, we observed a decrease in amplitude of the inward rectifying current at 
48h post SE when the outward current reaches its maximum amplitude. This pattern of 
activation resembles that observed in cultured microglia in which application of the pro-
inflammatory toxin lipopolysaccharide (LPS) induces the expression of outward currents 
together with the decrease in amplitude of the already present inward rectifying current 
(Boucsein et al., 2000). Thus, changes in intrinsic membrane properties during the activation 
of microglia follow the same sequence of events in the three experimental conditions where 
they have been studied (i.e. in cultures, in vivo after axotomy and after status epilepticus). 
Therefore, in contrast with some other aspects of microglia activation (see below and 
(Hanisch and Kettenmann, 2007) for review), up-regulation of potassium channels does not 
seem to be differentially regulated according to the context of the activation. It is worth 
noting, however, that the up-regulation of different potassium channels may be a prerequisite 
for triggering different subsequent aspects of microglia activation (Fordyce et al., 
2005;Pannasch et al., 2006;Franciosi et al., 2006;Kaushal et al., 2007). 
 
Enhanced purinergic responses in activated microglia 
Microglial cells express both metabotrobic (P2Y) and ionotropic (P2X) purinergic receptors. 
Accordingly and in agreement with previous studies (Boucsein et al., 2003;Wu et al., 2007), 
we found that ATP application evoked complex responses composed of inward and outward 
currents. By investigating separately P2X and P2Y receptor mediated responses, we found 
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that both ionotropic and metabotropic components of purinergic responses were enhanced in 
activated microglia following SE. This enhancement of purinergic responses probably 
involves an increased expression of the corresponding receptor since P2X and P2Y mRNAs 
were up-regulated in the epileptic hippocampus. Our study provides electrophysiological 
evidence that activation of microglia in situ involves an increase of all types of purinergic 
responses.  
Pharmacological investigations point toward a major role of P2X7 receptors in the ATP 
response mediated by ionotropic receptors which were increased in divalent cation free 
solution and strongly reduced by BBG. Though, an iso-PPADS sensitive but BBG resistant 
component was found in activated microglia, suggesting that the enhanced purinergic 
response would be partially mediated also by another type of P2X receptors, among which 
P2X1 is a possible candidate. However, the rapid desensitization and the poor selectivity of 
pharmacological tools available for ionotropic purinergic receptors makes their study difficult 
in slices and imposes caution in the interpretation of results about the role of specific receptor 
subtype. In models of LPS-induced inflammation, P2X7 receptors support the release of IL-
1beta by microglia (Ferrari et al., 1997;Rampe et al., 2004;Choi et al., 2007;Mingam et al., 
2008) but they probably also regulate indirectly the expression or release of other 
inflammatory factors such as cyclooxygenase-2, IL-6, IL-12 and TNFalpha (Rampe et al., 
2004;Choi et al., 2007). P2X7 receptors, probably in association with Pannexin-1 (Pelegrin 
and Surprenant, 2006) could therefore play a central role in the secretion of inflammatory 
mediators which occurs during the 48 hours that follow SE as these receptors could also 
control the microglia proliferation (Bianco et al., 2006). Finally, the observation that P2X7 
(and other P2 receptors see below) expression is significantly enhanced after the induction of 
the SE while the cytokine expression is also enhanced suggests the occurrence of a positive 
feedback mechanism exacerbating the activation process.  
The most dramatic difference we observed between non-activated and activated microglia is 
the up-regulation of P2Y6 receptors. The mRNA expression already increased 3 hours after 
SE and reaches a plateau between 24 and 48 hours when electrophysiological responses to 
UDP are 6 times larger than in non-activated microglia. This increased expression of P2Y6 
receptors has been observed in other models of microglia activation in vitro but also in vivo 
(Bianco et al., 2005;Koizumi et al., 2007). Accordingly, this receptor sustains a key function 
of microglia since its activation is essential in triggering phagocytosis (Koizumi et al., 2007). 
Thus, enhanced UDP mediated currents observed in the present study would mediate the 
enhanced phagocytic action observed in microglia of epileptic animals (Koizumi et al., 2007). 
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Non-activated microglia constantly move their processes to probe their environment (Davalos 
et al., 2005;Nimmerjahn et al., 2005). Following a local lesion, microglia cells send their 
process toward the lesion and ATP has been proposed to be one of the “alarm signals” since a 
source of exogenous ATP (or ATP analogue) mimics this phenomenon in vivo (Davalos et al., 
2005;Haynes et al., 2006) as well as in slices (Wu et al., 2007). P2Y12 receptors mediate this 
chemotaxis (Haynes et al., 2006) and the potassium currents induced by the activation of 
P2Y12 receptor seem also to be essential (Wu et al., 2007). Our results show that activated 
microglial cells respond to a P2Y12-13 receptor agonist (2-MeSADP) with larger outward 
potassium currents and, as a functional consequence, the velocity with which their processes 
reach a source of 2-MeSADP is twice faster than for non-activated microglia. Despite the lack 
of evidence for the involvement of P2Y13 receptors in microglia chemotaxis and the fact that 
up-regulation of P2Y12 receptor mRNAs is twice larger than that of P2Y13 receptors in the 
epileptic hippocampus, we cannot totally rule out the possibility that P2Y13 receptors 
contribute to the increase in velocity of microglia processes after SE. It worth noting, 
however, that P2Y13 transcripts but not receptor proteins were detected in brain microglia 
(Moller et al., 2000;Haynes et al., 2006). Thus, increase in both P2Y6 and P2Y12 receptor-
mediated responses confers to activated microglia the ability to intervene faster onto damaged 
cells since they would have larger responses to both the “eat-me” and “find me” signals. 
 
A specific activation state of microglia after status epilepticus 
The analysis of purinergic responses reveals striking differences between models of microglia 
activation. In contrast to the up-regulation of P2X7 receptors that we observed, a down 
regulation of P2X7 receptors has been reported in cultured microglia stimulated with LPS 
(Bianco et al., 2005), suggesting that regulation of P2X7 receptors is dependent on the 
stimulus or on the context in which activation is induced. Along the same line, we observed 
that P2Y12 mRNAs are up-regulated and P2Y12 receptor-mediated responses are increased in 
activated microglia of the epileptic hippocampus. This is in agreement with the increased 
expression of P2Y12 receptor observed in spinal chord microglia in a model of neuropathic 
pain (Kobayashi et al., 2008) but contrasts markedly with the down regulation of this receptor 
in models of neuronal injury in vitro, of LPS injection in vivo and in vitro (Moller et al., 
2000;Haynes et al., 2006). In these latter models, the down-regulation of P2Y12 receptors 
correlates with the progression of microglia morphology toward an amoeboid state (Haynes et 
al., 2006). Interestingly, microglial cells in the hippocampus after SE, which clearly maintains 
their expression of P2Y12 receptors (see supplementary fig. 1), undergo morphological 
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changes but never progress toward a full amoeboid morphology. Thus, the absence of 
amoeboid microglia together with the up-regulation of P2X7 and P2Y12 receptors indicate 
that microglia in the epileptic hippocampus is in a specific activation state which differs from 
that occurring during stronger inflammatory reactions triggered by severe neuronal injury or 
by LPS. This state, characterized by a maintained ability to release cytokines (P2X7) and by 
an enhanced chemotaxis (P2Y12), might be correlated with the persistent hyper-excitability of 
the hippocampal neuronal networks which outlasts the duration of the status epilepticus per 
se. Whether microglia acquires a similar functional state in other brain disorders associated 
with chronic and probably milder inflammation remains to be studied. 
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Figure Legends: 
 
Figure 1. Status epilepticus induced by intraperitoneal kainate injection triggers 
inflammation, neuronal death in the hippocampus and long term changes in EEG activity in 
CXCR1eGFP/+ mice. A, Changes in expression of pro-inflammatory markers in the 
hippocampus analyzed by qPCR at different time points after induction of the status 
epilepticus. Ten to 20 fold increase in mRNA expression for IL-1β, IL-6, TNF-α and COX-2 
changes were observed at 3h (n=4 mice) compared to control (PBS; n=4). Significant 
increased expression persisted at 24h (n=6) for all mRNA species and became more variable 
at 48 hours (n=6). B, Fluorojade B (left panels) and Eosine-hematoxylin staining (right 
panels) in the CA1 area of the ventral hippocampus in PBS (top panels) and kainate-injected 
mice (bottom panels) 48h after the status epilepticus. Note the strong staining of the 
pyramidal cell layer with both techniques in kainate injected mice. Scale bar 200 µm. C, 
Representative cortical EEG-recording from a mouse 2 months after induction of status 
epilepticus. The representative trace exhibits spontaneous collective activity in a form burst of 
spikes discharges. The burst is showed at higher temporal resolution in the inset, where 
individual spike discharge can be identified. 
 
Figure 2. Increase in size and number of microglia in the hippocampus after status 
epilepticus. A. Confocal images (stack of 21 z sections, 8.28 µm total thickness) of Iba1 
immunostaining and GFP fluorescence in the CA1 stratum radium of CX3CR1eGFP/+ mice in 
control conditions (top panels) and 24h after induction of the status epilepticus (bottom 
panels). The two markers are co-localised, confirming that GFP expressing cells are 
microglia. Note the stronger Iba1 immunoreactivity, the larger somata and the thicker 
proximal processes of activated microglia. Scale bar 15 µm. B, Western blot analysis of Iba1 
expression in the hippocampus of control and kainate-injected animals after 24 and 48h. 
Samples were obtained from hippocampi of 3 animals for each condition. C, Quantification of 
microglial cell number in fields of view of 230x230 µm in the CA1 area of control (n=4) and 
treated mice 24h (n=3) and 48h (n=7) after the induction of the status epilepticus. The number 
of microglial cells was significantly larger already at 24h and had doubled at 48h. ** p< 0.01 
 
Figure 3. Microglia proliferates after status epilepticus. Confocal images of GFP fluorescence 
and of immunostaining of the proliferation markers Ki67 (left series of panels, scale bar 25 
µm) and Mac-2 (right series of panels, scale bar 40µm). Representative pictures (stack of 5 z 
 29 
sections, 4.5 µm total thickness) of the CA1 hippocampal region obtained from PBS injected 
mice and from mice sacrificed 3, 24, and 48h after the induction of status epilepticus. 
Immunostaining for both markers, highly co-localized with GFP, is first observed at 24h and 
increases at 48h. 
 
Figure 4. Time dependent changes in intrinsic electrophysiological properties of microglia 
after status epilepticus. A, Temporal course of input resistance (left panel) and membrane 
capacitance (right panel) changes of CA1 hippocampal microglial cells after status 
epilepticus. * p<0.05, ** p< 0.01. B, Examples of current responses induced by voltage steps 
of 20 mV increment from -140 to +60mV (holding potential -60mV) in microglia cells of 
control (left panel, black traces) and KA injected animals 48h after status epilepticus (right 
panel, gray traces). C, I/V curves obtained from microglial cells recorded from control mice 
(black squares, n=35) and from mice 3 h (open circles, n=7), 24h (half filled circles, n=15) 
and 48h (filled circles, n=39). Current densities were considered to take into account changes 
in membrane capacitance in activated microglia. Note the appearance of inward rectifying 
currents at hyperpolarized potentials and of outward currents at depolarized potentials 24h 
after the status epilepticus. Note also that the inward rectifying currents decrease while the 
outward currents increase at 48h. There was no significant difference between the I/V curves 
of control and 3h conditions. 
 
Figure 5. Status epilepticus induces an increase of purinergic receptor mRNA expression in 
the hippocampus. A) Quantitative PCR of purinergic receptors in whole hippocampi from 
control animals (n=4) and from treated animals at 3h (n=4), 24h (n=6) and 48h (n=6) after the 
status epilepticus. Note that the expression of P2Y6 was already increased at 3h while that of 
other receptors was increased at 24h or 48h. 
 
Figure 6. Larger P2X receptor-mediated responses in activated microglia. A, B, Examples of 
currents induced by bath application of ATP (black bars, 1mM, 2 minutes) in microglia from 
control animals (left panel, black traces) and from mice 48h after a status epilepticus (right 
panel, gray traces) in normal (A) and Mg2+- Ca2+-free medium (B). Cells were patched with a 
Cs-gluconate based internal solution and hold at -40mV. The vertical fast deflexions 
correspond to currents generated by voltage step series applied to obtain the I/V curves of the 
ATP responses shown on the right. Graphs on the right represent the average of ATP induced 
current density/voltage relation in control (black squares, n=12 for control medium and n=6 
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for Ca2+-Mg2+-free medium) and 48h after status epilepticus (gray circles, n=13 for control 
medium and n=9 for Ca2+-Mg2+-free medium) obtained by subtracting I/V curve obtained 
before from that obtained during ATP application. C, Pharmacology of the P2X receptor-
mediated responses induced by ATP (1 mM) application at -40mV in control (black bars) and 
48h after status epilepticus induction (gray bars). Responses were enhanced in Mg2+- Ca2+-
free medium and strongly reduced by Brilliant Blue G (BBG, 3µM) in control as in activated 
microglia. However, a residual current which was blocked by further addition of isoPPADS 
(50 µM) was present in activated microglia. * p<0.05, ** p< 0.01. 
 
Figure 7. Larger P2Y6 and P2Y12 receptor-mediated responses in activated microglia. A, 
Examples of currents induced by bath application of the P2Y6 receptor agonist UDP (black 
bars, 1mM, 1 minute) in microglia from a control animal (left panel, black trace) and from a 
mice 48h after the status epilepticus (right panel, gray trace). Cells were patched with K-
gluconate based solution and responses were tested at -20mV. B, I/V curve of the UDP 
induced responses in control (black symbols, n=9) and epileptic mice (gray symbols, n=8). C, 
Same as in (B) for the P2Y12 receptor mediated responses induced by the selective agonist 2-
MeSADP application (100µM, 1 minute). Numbers of microglia are 11 in control (black 
bar/symbols) and 7 in treated mice (gray bar/symbols). * p<0.05. 
 
Figure 8. Higher motility of microglia processes after a status epilepticus. A, Examples of 
fluorescence images at different time point after the insertion (at t=0, first column) in the slice 
of a pipette containing 2-MeSADP (100µM) in control (upper row) and 48h after the 
induction of a status epilepticus (bottom panels). The pictures at t=15 min (second column) 
show the formation of a ring of fluorescence corresponding to microglia processes elongated 
from cells at the periphery of the field of view towards the pipette tip in the center. At t=25 
min (right column) the processes of activated microglia have reached the pipette (lower 
picture) while those of microglia from control mice have not yet completed their extension 
(upper picture). Scale bar: 50 µm. B, Normalised ratio of the internal over the external circle 
fluorescence (top, left panel; see methods) in experiments on control (black, n=5 slices) and 
epileptic (red, n=6 slices) mice 48h after status epilepticus. This ratio increases when the 
fibres approach the pipette and reaches its maximum when all the processes are within the 
central circle. C, Temporal evolution of the total fluorescence measured in concentric rings 
(orange second, red third, blue 4th, green 5th , order starting from the external light blue ring). 
Left and right panels correspond to the example in control (top panels in A) and 48h after 
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status epilepticus induction (bottom panels in A), respectively. The distance between peaks 
provides a measure of the velocity of the processes. Averages of the velocity measured in 
slices of control (black, n=7 ) and epileptic (red, n=4) mice are represented on the histogram 
in inset. ** p< 0.01. 
 
Supplemental figure 1. Activated microglia cells still express P2Y12 receptors. Confocal 
images (stack of 13 z sections, 11.7 µm total thickness) of eGFP fluorescence and P2Y12 
immunostaining in the CA1 stratum radium of CX3CR1eGFP/+ mice in control conditions (top 
panels) and 48h after induction of the status epilepticus (bottom panels). The two markers are 
co-localized, confirming that P2Y12 is expressed only in microglia. Scale bar 20 µm. 
 
Supplemental figure 2. Purinergic responses in microglia are not affected by reducing 
synaptic transmission. Examples of currents induced in microglia of control animals by bath 
application of ATP (A, 1mM for 2 minutes), UDP (B, 1mM for 1minute) and 2-MeSADP (C, 
100µM for 1minute) in the presence of TTX (1µM), NBQX (20µM), gabazine (10µM), D-
AP5 (20µM). In panels B and C, LY341495 (100µM), DPCPX (1µM) were also added. The 
histograms show the comparison of the agonist-induced currents in control experiments 
(black bars, same data as those of figures 6 and 7) and in experiments done in presence of the 
cocktails of antagonists (hatched bars, n=4 for each case). Reduction of neuronal and synaptic 
activities did not change the mean amplitudes of the currents induced by purinergic receptor 
agonists. 
 
Supplemental Video 1. Motility of microglial cell processes towards a point source of P2Y12 
receptor agonist. This movie shows the dynamics of microglial cell processes after the 
insertion of a pipette containing 2-MeSADP (100µM) in an acute hippocampal slice of a PBS 
injected animal. After the insertion of the pipette, the microglial processes extend towards the 
pipette tip (red spot) and reach it in about 1 hour. Images were taken once every minute. 
 
Supplemental Video 2. Increased motility of microglial cell processes after a status 
epilepticus. Same experimental conditions as in supplemental video 1 on a hippocampal slice 
of kainate-injected animal 48 hours after status epilepticus. The extension of the processes 
towards the pipette tip (red spot) containing 2-MeSADP (100µM) was faster than in control 
animals and was completed in less than 30 minutes. Images were taken once every minute. 
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